Yuling Li

Yuling Li is the founder of Innoforce Pharmaceuticals. Innoforce Pharmaceuticals has raised $120M in total funding. Latest round: Series A.

About Yuling Li

Yuling Li is the CEO of Innoforce Pharmaceuticals, a biopharmaceutical innovation company founded in 2018 in Hangzhou, China. The company specializes in developing advanced therapies, including cell and gene therapies, RNA manufacturing platforms, and other biopharmaceutical products. Innoforce Pharmaceuticals has completed a Series A financing round of $96M (625M CNY) in March 2021, co-led by South China Venture Capital and Yanchuang Capital, and a Pre-A financing of $24M (170M CNY) in June 2020. The company's business model involves a structured transaction model with B2B and direct-to-consumer sales, leveraging partnerships with distributors.

Yuling Li at a glance

More founders in Hangzhou, Zhejiang, China (28)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades